Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 5
Journal homepage
812
Views
46
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis

Yubo MaDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; View further author information
,
Meng WuDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; View further author information
,
Xu ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; View further author information
,
Qing XiaDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; View further author information
,
Jiajia YangDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; View further author information
,
Shengqian XuDepartment of Rheumatism and Immunity, The First Affiliated Hospital of Anhui Medical University, Hefei, PR ChinaView further author information
&
Faming PanDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, PR China; ;The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, PR China; Correspondence[email protected]
View further author information
 show all
Pages 849-857 | Received 12 Oct 2017, Accepted 05 Dec 2017, Published online: 08 Feb 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.